en

PRODUCT DETAIL

Fulvestrant Fresenius Kabi 250 mg

Code 5610D
MA number 34/0215/20-S
Product Form: sol iru 2x5 ml/250 mg (striek.inj.napl.+2 ihly)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 34 - ANTIHORMONA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BA03 Fulvestrant
Shelf life: 24
Container: glass pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 30.09.2020
Validity: 30.09.2025
Pediatric warnings: Yes
SPC: SPC_Fulvestrant Fresenius Kabi 250 mg_september_2020.docx  
PIL: PIL_Fulvestrant_Fresenius Kabi 250 mg_september_2020.docx  
Safety feature Yes
Data update: 02.10.2020
eu-flag.png sk-flag.png